Drug · DIN 02242502
ONE-ALPHA
SINGLE-USE AMPOULES
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 31, 2022; first marketed February 20, 2001.
- Drug Identification Number (DIN)
- 02242502
- Company (DIN owner)
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Alfacalcidol A11CC03
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALFACALCIDOL | 2 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 29, 2022: NOC 27492New Drug Submission (NDS) · Change in Product Ownership; Change in the layout and content of the packaging material; Converting the Product Monograph to the 2020 format.
- July 21, 2000: NOC 952Supplement to a New Drug Submission (SNDS) · New indication: secondary hyperparathyroidism
- July 21, 2000: NOC 953Supplement to a New Drug Submission (SNDS) · New dosage form: solution for injection 2mcg/ml
Other DINs named ONE-ALPHA
- DIN 00474517 · Marketed
- DIN 00474525 · Marketed
- DIN 02240329 · Marketed
- DIN 02239431 · Cancelled Pre Market